122830
122830 operates in various business sectors.
Market Cap & Net Worth: 122830 (122830)
122830 (KO:122830) has a market capitalization of $9.15K (₩13.39 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #45029 globally and #2589 in its home market, demonstrating a -27.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 122830's stock price ₩1449.00 by its total outstanding shares 9241 (9.24K).
122830 Market Cap History: 2021 to 2026
122830's market capitalization history from 2021 to 2026. Data shows growth from $2.65K to $9.15K (32.36% CAGR).
122830 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 122830's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 122830 by Market Capitalization
Companies near 122830 in the global market cap rankings as of March 18, 2026.
Key companies related to 122830 by market ranking:
- Entest Biomedical Inc (PINK:ETNI): Ranked #45020 globally with a market cap of $9.83K USD.
- ENGEN BOTSTWANA LIMITED (XBOT:ENG-EQO): Ranked #45021 globally with a market cap of $9.82K USD ( BWP138.08K BWP).
- THROMBOGENICS (BE:TG4): Ranked #45030 globally with a market cap of $9.73K USD ( €9.48K EUR).
- Nutralife Biosciences Inc (PINK:NLBS): Ranked #45031 globally with a market cap of $9.73K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #45020 | Entest Biomedical Inc | PINK:ETNI | $9.83K | $0.00 |
| #45021 | ENGEN BOTSTWANA LIMITED | XBOT:ENG-EQO | $9.82K | BWP14.25 |
| #45030 | THROMBOGENICS | BE:TG4 | $9.73K | €1.00 |
| #45031 | Nutralife Biosciences Inc | PINK:NLBS | $9.73K | $0.00 |
122830 Historical Marketcap From 2021 to 2026
Between 2021 and today, 122830's market cap moved from $2.65K to $ 9.15K, with a yearly change of 32.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩9.15K | -35.46% |
| 2025 | ₩14.17K | +25.49% |
| 2024 | ₩11.29K | +32.52% |
| 2023 | ₩8.52K | -25.00% |
| 2022 | ₩11.36K | +328.57% |
| 2021 | ₩2.65K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of 122830 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.15K USD |
| MoneyControl | $9.15K USD |
| MarketWatch | $9.15K USD |
| marketcap.company | $9.15K USD |
| Reuters | $9.15K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.